VanEck Associates’s Kadant KAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
4,404
+2,106
+92% +$656K ﹤0.01% 1088
2026
Q1
$672K Buy
2,298
+1,013
+79% +$325K ﹤0.01% 1141
2025
Q4
$366K Buy
1,285
+731
+132% +$208K ﹤0.01% 1220
2025
Q3
$165K Buy
554
+81
+17% +$26.4K ﹤0.01% 1290
2025
Q2
$150K Sell
473
-10,336
-96% -$3.24M ﹤0.01% 1276
2025
Q1
$3.64M Buy
10,809
+1,045
+11% +$380K ﹤0.01% 827
2024
Q4
$3.37M Buy
+9,764
New +$3.54M ﹤0.01% 827

Other funds holding KAI

VanEck Associates's KAI Position: Q2 2026 in Review

VanEck Associates increased its Kadant (KAI) stake by 92% in Q2 2026, buying an estimated $656K and bringing the position to 4,404 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

VanEck Associates first reported a position in KAI in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.64M in Q1 2025. 326 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • VanEck Associates held 4,404 shares of Kadant worth $1.38M as of Q2 2026.
  • VanEck Associates bought 2,106 Kadant shares in Q2 2026, an estimated $656K.
  • Kadant made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1088 holding.
  • VanEck Associates first reported a position in Kadant in Q4 2024 and has held it in 7 quarters since.
  • VanEck Associates's Kadant position peaked at $3.64M in Q1 2025.
  • 326 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.